Key points are not available for this paper at this time.
The FDA has approved a new radiopharmaceutical agent to assist in detecting causes of cognitive impairment other than Alzheimer's disease. But unique features of imaging information obtained with florbetapir F18 injection require careful consideration in diagnosis.
Building similarity graph...
Analyzing shared references across papers
Loading...
Lucie Yang
University of Toronto
Dwaine Rieves
National Institutes of Health
Charles J. Ganley
United States Food and Drug Administration
New England Journal of Medicine
Center for Drug Evaluation and Research
Building similarity graph...
Analyzing shared references across papers
Loading...
Yang et al. (Wed,) studied this question.
synapsesocial.com/papers/6a0137786be84a7ac885a459 — DOI: https://doi.org/10.1056/nejmp1208061